Houston TX 血液疾病临床试验
9项针对 血液疾病的研究正在 Houston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
招募中3 期
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
招募中3 期
- Quetzal Site 6, Houston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Baylor College of Medicine, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
招募中2 期
- The University of Texas MD Anderson Cancer Center, Houston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Baylor College of Medicine, Houston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
招募中观察性研究
- Gulf States Hemophilia and Thrombophilia Center, Houston
- Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
招募中2/3 期
- MD Anderson Cancer Center, Houston
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
招募中1 期
- The University of Texas MD Anderson Cancer Center, Houston
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
招募中1 期
- MD Anderson Cancer Center, Houston
其他城市的 血液疾病试验
- Atlanta, GA10 项研究
- Boston, MA10 项研究
- Los Angeles, CA9 项研究
- The Bronx, NY8 项研究
- New York City, NY7 项研究
- Nashville, TN7 项研究
- Mountain View, CA6 项研究
- Durham, NC5 项研究
- Greenville, NC5 项研究
- Seattle, WA5 项研究
- Washington, DC5 项研究
- Portland, OR5 项研究
Houston的其他研究
- 非小细胞肺癌145 项研究
- 乳腺癌126 项研究
- 癌症（所有类型）121 项研究
- 转移性癌症104 项研究
- 结直肠癌102 项研究
- 卵巢癌89 项研究
- 急性髓系白血病85 项研究
- 肺癌78 项研究
- 前列腺癌76 项研究
- 子宫内膜癌68 项研究
- 胰腺癌61 项研究
- 黑色素瘤59 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。